Yunnan Baiyao GroupLtd Management
Management criteria checks 3/4
Yunnan Baiyao GroupLtd's CEO is Ming Dong, appointed in Mar 2021, has a tenure of 3.75 years. directly owns 0.001% of the company’s shares, worth CN¥791.82K. The average tenure of the management team and the board of directors is 2.7 years and 4.5 years respectively.
Key information
Ming Dong
Chief executive officer
CN¥4.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.8yrs |
| CEO ownership | 0.0007% |
| Management average tenure | 2.7yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Calculating The Fair Value Of Yunnan Baiyao Group Co.,Ltd (SZSE:000538)
Oct 03
Yunnan Baiyao Group Co.,Ltd's (SZSE:000538) Business And Shares Still Trailing The Market
Sep 15Yunnan Baiyao GroupLtd (SZSE:000538) Could Easily Take On More Debt
Aug 06A Look At The Intrinsic Value Of Yunnan Baiyao Group Co.,Ltd (SZSE:000538)
Jun 30Earnings Working Against Yunnan Baiyao Group Co.,Ltd's (SZSE:000538) Share Price
Apr 21Yunnan Baiyao Group Co.,Ltd Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Apr 02Yunnan Baiyao Group Co.,Ltd (SZSE:000538) Shares Could Be 34% Above Their Intrinsic Value Estimate
Feb 27CEO
Ming Dong (48 yo)
3.8yrs
Tenure
CN¥4,251,000
Compensation
Mr. Ming Dong serves as Executive Director of Shanghai Pharmaceuticals Holding Co., Ltd since June 29, 2023. He serves as Chairman of the Board of YNBY International Limited (formerly known as Ban Loong Ho...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 3.8yrs | CN¥4.25m | 0.00074% CN¥ 791.8k | |
| Chief Financial Officer | 2.5yrs | CN¥1.84m | no data | |
| Chief Scientist | 2.9yrs | CN¥3.61m | no data | |
| Chief Compliance Officer & Senior VP | no data | CN¥2.76m | 0.0057% CN¥ 6.1m | |
| Chief Quality & Process Officer | no data | CN¥1.24m | no data | |
| Chief Innovation Officer | no data | CN¥3.64m | 0.028% CN¥ 30.2m | |
| Chief Commercial Officer & Senior VP | 1.8yrs | CN¥3.64m | no data | |
| Strategic Scientist of Chinese Medicine | no data | CN¥1.71m | no data | |
| Securities Representative | no data | no data | no data |
2.7yrs
Average Tenure
56.5yo
Average Age
Experienced Management: 000538's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.1yrs | CN¥4.25m | 0.00074% CN¥ 791.8k | |
| Independent Director | 3.6yrs | CN¥257.10k | no data | |
| Independent Director | 5.3yrs | CN¥257.10k | no data | |
| Non-Independent Director | 2.1yrs | CN¥1.17m | no data | |
| Chairman of the Board | less than a year | no data | no data | |
| Independent Director | 5.3yrs | CN¥256.00k | no data | |
| Shareholder Representative Chairman of the Supervisory Board | 5.3yrs | no data | no data | |
| Shareholder Representative Vice Chairman of the Supervisory Board | 5.3yrs | no data | no data | |
| Non-Independent Director | 5.3yrs | no data | 0.70% CN¥ 751.3m | |
| Non-Independent Director | 5.3yrs | CN¥1.13m | 0.0099% CN¥ 10.6m | |
| Non-Independent Director | 2.1yrs | CN¥1.01m | no data | |
| Non-Independent Director | 2.1yrs | no data | no data |
4.5yrs
Average Tenure
55.5yo
Average Age
Experienced Board: 000538's board of directors are considered experienced (4.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:34 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yunnan Baiyao Group Co.,Ltd is covered by 38 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sandra Sun | BofA Global Research |
| Shuchang Liu | Changjiang Securities Co. LTD. |
| YANG QIAO | Changjiang Securities Co. LTD. |